Literature DB >> 17401676

PEN-2 overexpression induces gamma-secretase protein and its activity with amyloid beta-42 production.

Su J Seo1, Dae Y Hwang, Jung S Cho, Kab R Chae, Chuel K Kim, Sun B Shim, Seung W Jee, Su H Lee, Ji S Sin, Soo Y Choi, Joon Kim, Yong K Kim.   

Abstract

PEN-2 is a component of the gamma-secretase complex, which is involved in the cleavage of the beta-amyloid precursor protein. The aim of this study was to determine the mechanism by which PEN-2 overexpression regulates gamma-secretase expression and the production of Abeta-42. In order to determine this, a hybrid gene harboring human PEN-2 was constructed, and used in the transfection of SK-N-MC human neuroepitheliomal cells. This cell line was also co-transfected with a combination of human mutant presenilin 2 (hPS2m) and APPsw. Our results indicated that (i) human PEN-2 overexpression induced an increase in gamma-secretase activity and its proteins, including PS1-CTF, APH-1, and nicastrin, thus production of Abeta-42, (ii) co-transfection of human PEN-2 with both hPS2m and APPsw exerted no more profound effects on the induction of gamma-secretase proteins and its activity than did transfection with hPEN-2 alone. Thus, PEN-2 overexpression may facilitate assembly into the more active gamma-secretase complex, and may also induce an increase in activity, thus affecting Abeta-42 production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401676     DOI: 10.1007/s11064-006-9262-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  16 in total

1.  PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin.

Authors:  Harald Steiner; Edith Winkler; Dieter Edbauer; Stefan Prokop; Gabriele Basset; Aya Yamasaki; Marcus Kostka; Christian Haass
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

2.  Overexpression of nicastrin increases Abeta production.

Authors:  M Paul Murphy; Pritam Das; Andrew C Nyborg; Marjorie J Rochette; Mark W Dodson; Nicole M Loosbrock; Terrance M Souder; Chris McLendon; Sami L Merit; Siân C Piper; Karen R Jansen; Todd E Golde
Journal:  FASEB J       Date:  2003-04-08       Impact factor: 5.191

3.  Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex.

Authors:  Stefan Prokop; Keiro Shirotani; Dieter Edbauer; Christian Haass; Harald Steiner
Journal:  J Biol Chem       Date:  2004-03-23       Impact factor: 5.157

4.  Tau and GSK3beta dephosphorylations are required for regulating Pin1 phosphorylation.

Authors:  Sae H Min; Jung S Cho; Jae H Oh; Sun B Shim; Dae Y Hwang; Su H Lee; Seung W Jee; Hwa J Lim; Min Y Kim; Yhun Y Sheen; Seok H Lee; Yong K Kim
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

5.  Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease.

Authors:  Dae Y Hwang; Kab R Chae; Tae S Kang; Jin H Hwang; Chae H Lim; Hyun K Kang; Jun S Goo; Mi R Lee; Hwa J Lim; Sae H Min; Jun Y Cho; Jin T Hong; Chi W Song; Sang G Paik; Jung S Cho; Yong K Kim
Journal:  FASEB J       Date:  2002-06       Impact factor: 5.191

6.  Nicastrin is required for gamma-secretase cleavage of the Drosophila Notch receptor.

Authors:  Yue Hu; Yihong Ye; Mark E Fortini
Journal:  Dev Cell       Date:  2002-01       Impact factor: 12.270

7.  aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation.

Authors:  Ross Francis; Garth McGrath; Jianhuan Zhang; David A Ruddy; Mary Sym; Javier Apfeld; Monique Nicoll; Mark Maxwell; Bing Hai; Michael C Ellis; Annette L Parks; Wei Xu; Jinhe Li; Mark Gurney; Richard L Myers; Carol S Himes; Ronald Hiebsch; Cara Ruble; Jeffrey S Nye; Daniel Curtis
Journal:  Dev Cell       Date:  2002-07       Impact factor: 12.270

8.  Regulated hyperaccumulation of presenilin-1 and the "gamma-secretase" complex. Evidence for differential intramembranous processing of transmembrane subatrates.

Authors:  Seong-Hun Kim; Takeshi Ikeuchi; Chunjiang Yu; Sangram S Sisodia
Journal:  J Biol Chem       Date:  2003-06-23       Impact factor: 5.157

9.  Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw.

Authors:  Dae Y Hwang; Jung S Cho; Su H Lee; Kab R Chae; Hwa J Lim; Sea H Min; Su J Seo; Youn S Song; Chi W Song; Sang G Paik; Yhun Y Sheen; Yong K Kim
Journal:  Exp Neurol       Date:  2004-03       Impact factor: 5.330

10.  Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP).

Authors:  Laura Marlow; Melissa Cain; Miguel A Pappolla; Kumar Sambamurti
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

View more
  5 in total

1.  The Transcriptional Regulatory Properties of Amyloid Beta 1-42 may Include Regulation of Genes Related to Neurodegeneration.

Authors:  Duygu Gezen-Ak; İrem L Atasoy; Esin Candaş; Merve Alaylıoğlu; Erdinç Dursun
Journal:  Neuromolecular Med       Date:  2018-06-12       Impact factor: 3.843

Review 2.  Molecular Pathogenesis of Alzheimer's Disease: An Update.

Authors:  Alfredo Sanabria-Castro; Ileana Alvarado-Echeverría; Cecilia Monge-Bonilla
Journal:  Ann Neurosci       Date:  2017-04-21

3.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.

Authors:  Raymond D Meng; Christopher C Shelton; Yue-Ming Li; Li-Xuan Qin; Daniel Notterman; Philip B Paty; Gary K Schwartz
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

4.  Nicastrin overexpression in transgenic mice induces aberrant behavior and APP processing.

Authors:  Jun Seo Goo; Yong Bin Kim; Sun Bo Shim; Seung Wan Jee; Su Hae Lee; Ji Een Kim; In Sik Hwang; Young Ju Lee; Moon Hwa Kwak; Chuel Ju Lim; Jin Tae Hong; Dae Youn Hwang
Journal:  Mol Neurobiol       Date:  2013-04-18       Impact factor: 5.590

5.  Γ-secretase components as predictors of breast cancer outcome.

Authors:  Hanna M Peltonen; Annakaisa Haapasalo; Mikko Hiltunen; Vesa Kataja; Veli-Matti Kosma; Arto Mannermaa
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.